Latest Breaking News On - Longboard pharmaceuticals trading down - Page 1 : comparemela.com

Cantor Fitzgerald Reaffirms Overweight Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Cantor Fitzgerald Reaffirms Overweight Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdTd asset management incAnalyst recommendations for longboard pharmaceuticalsBourgeon capital managementLongboard pharmaceuticalsJennison associatesHedge funds weigh in on longboard pharmaceuticalsAsset management incCantor fitzgeraldNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticals trading downLongboard pharmaceuticals incPolar capital holdings plcFree reportPharmaceuticals trading downGet free report

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $21 30

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $21 30
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticals company profileAsset management incJennison associatesLongboard pharmaceuticals incLongboard pharmaceuticalsPolar capital holdings plcPlatinum investment management ltdCantor fitzgeraldParkman healthcare partnersLongboard pharmaceuticals trading downGet free reportPharmaceuticals trading downCapital holdings plcHealthcare partners

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns Overweight Rating from Cantor Fitzgerald

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns Overweight Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) Short Interest Up 165 2% in June

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 732,800 shares, an increase of 165.2% from the June 15th total of 276,300 shares. Currently, 5.2% of the company’s shares are short sold. […]

News ratings for longboard pharmaceuticals dailyBourgeon capital managementAsset management incLongboard pharmaceuticals incLongboard pharmaceuticals trading downHedge funds weigh in on longboard pharmaceuticalsLongboard pharmaceuticalsHealth asset managementLongboard pharmaceuticals company profileCantor fitzgeraldBlackrock incGet free reportPharmaceuticals trading downCapital managementManagement incProsight management

B Riley Comments on Longboard Pharmaceuticals, Inc s Q2 2023 Earnings (NASDAQ:LBPH)

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) – Research analysts at B. Riley issued their Q2 2023 earnings per share (EPS) estimates for Longboard Pharmaceuticals in a report issued on Wednesday, May 10th. B. Riley analyst K. Patel anticipates that the company will post earnings per share of ($0.55) for the quarter. B. Riley currently […]

Institutional trading of longboard pharmaceuticalsBourgeon capital managementHealth asset managementLongboard pharmaceuticals trading downCantor fitzgeraldLongboard pharmaceuticals company profileBlackrock incNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticalsLongboard pharmaceuticals incGet ratingLongboard pharmaceuticalPharmaceuticals trading downCapital managementLongboard pharmaceuticals dailyNasdaq lbph